Clal Biotechnology Industries Ltd. (CBI.TA)
ILA 35.6
(-0.84%)
ILA 35.6
(-0.84%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 104 Thousand | 370 Thousand | 76.96 Million | 74.54 Million | 113.29 Million | 12.76 Million |
| Cost of Revenue | - | - | 66.24 Million | 68.32 Million | 57.89 Million | 17.6 Million |
| Gross Profit | 104 Thousand | 370 Thousand | 10.72 Million | 6.21 Million | 55.39 Million | -4.83 Million |
| Operating Expenses | 104 Thousand | 12.87 Million | 77.46 Million | 67.17 Million | 67.83 Million | 80.58 Million |
| Selling, General and Administrative Expenses | 5.48 Million | 6.51 Million | 20.01 Million | 18.38 Million | 20.22 Million | 23.34 Million |
| Research and Development Expenses | - | 24.81 Million | 33.07 Million | 26.35 Million | 9.95 Million | 9.16 Million |
| Other Expenses | -5.38 Million | 24.14 Million | -782 Thousand | 271 Thousand | -3.92 Million | 447 Thousand |
| Cost and Expenses | 104 Thousand | 12.87 Million | 143.71 Million | 135.49 Million | 125.73 Million | 98.18 Million |
| Operating Income | - | 100.61 Million | -101.2 Million | -83.64 Million | -79.86 Million | -90.96 Million |
| Interest Expense | 3.54 Million | 3.72 Million | 7.42 Million | 4.25 Million | 18.6 Million | 35.31 Million |
| Income Tax Expense | 107.77 Million | 113.95 Million | 89 Thousand | -59.19 Million | -31.72 Million | -12 Million |
| Earnings before Tax | 79.68 Million | 52.21 Million | -128.12 Million | 49.83 Million | -357.94 Million | -40.86 Million |
| Net Income | -31.05 Million | -61.74 Million | -89.58 Million | 109.02 Million | -154.11 Million | -44.94 Million |
| Earnings Per Share Basic | -0.20 | -0.39 | -0.57 | 0.68 | -0.96 | -0.28 |
| Earnings Per Share Diluted | -0.20 | -0.39 | -0.57 | 0.68 | -0.96 | -0.28 |
| Weighted Average Shares Outstanding | 156.84 Million | 156.84 Million | 158.44 Million | 161.23 Million | 161.23 Million | 158.53 Million |
| Weighted Average Shares Outstanding (Diluted) | 156.84 Million | 156.84 Million | 158.44 Million | 161.23 Million | 161.23 Million | 158.53 Million |
| Gross Margin | 1.00 | 1.00 | 0.14 | 0.08 | 0.49 | -0.38 |
| EBIT Margin | 74.29 | 319.62 | -1.02 | -0.80 | -0.52 | -5.96 |
| Profit Margin | -298.57 | -166.86 | -1.16 | 1.46 | -1.36 | -3.52 |
| EBITDA | 7.72 Million | 64.21 Million | -78.68 Million | 13.22 Million | -58.84 Million | -76.12 Million |
| Earnings Before Tax Margin | - | 271.93 | -1.31 | -1.12 | -0.70 | -7.13 |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 16 Thousand | 104 Thousand | 16 Thousand | 36 Thousand | 36 Thousand | 370 Thousand |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | 16 Thousand | 104 Thousand | 16 Thousand | 36 Thousand | 36 Thousand | 370 Thousand |
| Operating Expenses | 15.39 Million | 10.28 Million | 15.39 Million | 3 Million | 3 Million | 12.87 Million |
| Selling, General and Administrative Expenses | 2.02 Million | - | 2.02 Million | 2.86 Million | 2.86 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | - | - | 24.14 Million |
| Cost and Expenses | 15.39 Million | 10.28 Million | 15.39 Million | 3 Million | 3 Million | 12.87 Million |
| Operating Income | -2.26 Million | 7.2 Million | -2.26 Million | -2.82 Million | -2.82 Million | 100.61 Million |
| Interest Expense | - | 3.54 Million | - | - | - | 3.72 Million |
| Income Tax Expense | 1.03 Million | 110.73 Million | 1.03 Million | 445.5 Thousand | 445.5 Thousand | 113.95 Million |
| Earnings before Tax | -15.7 Million | 79.68 Million | -15.7 Million | 1.65 Million | 1.65 Million | 52.21 Million |
| Net Income | -16.73 Million | -31.05 Million | -16.73 Million | 1.21 Million | 1.21 Million | -61.74 Million |
| Earnings Per Share Basic | -0.09 | - | -0.09 | 0.01 | 0.01 | - |
| Earnings Per Share Diluted | -0.09 | - | -0.09 | 0.01 | 0.01 | - |
| Weighted Average Shares Outstanding | 192.44 Million | 156.84 Million | 192.44 Million | 121.25 Million | 121.25 Million | 156.84 Million |
| Weighted Average Shares Outstanding (Diluted) | 192.44 Million | 156.84 Million | 192.44 Million | 121.25 Million | 121.25 Million | 156.84 Million |
| Gross Margin | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | 125.59 | - | -139.34 | -74.82 | -74.82 | - |
| Profit Margin | -1046.12 | -298.57 | -1046.12 | 33.68 | 33.68 | -166.86 |
| EBITDA | 2 Million | - | -2.22 Million | -2.69 Million | -2.69 Million | - |
| Earnings Before Tax Margin | -141.66 | 69.23 | -141.66 | -78.44 | -78.44 | 271.93 |
000937
NNBR
FBK
SPYR
MWY
WTER